127 related articles for article (PubMed ID: 36192262)
21. The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder.
Luzzago S; Palumbo C; Rosiello G; Pecoraro A; Deuker M; Tian Z; Shariat SF; Saad F; de Cobelli O; Karakiewicz PI
J Surg Oncol; 2019 Dec; 120(7):1266-1275. PubMed ID: 31562831
[TBL] [Abstract][Full Text] [Related]
22. Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities.
Cano Garcia C; Piccinelli ML; Tappero S; Panunzio A; Barletta F; Incesu RB; Tian Z; Saad F; Briganti A; Terrone C; Shariat SF; Graefen M; Tilki D; Antonelli A; De Cobelli O; Kosiba M; Banek S; Kluth LA; Chun FKH; Karakiewicz PI
Int Urol Nephrol; 2023 May; 55(5):1117-1123. PubMed ID: 36813873
[TBL] [Abstract][Full Text] [Related]
23. Oncological impact of inflammatory biomarkers in elderly patients treated with radical cystectomy for urothelial bladder cancer.
Mari A; Muto G; Di Maida F; Tellini R; Bossa R; Bisegna C; Campi R; Cocci A; Viola L; Grosso A; Scelzi S; Lapini A; Carini M; Minervini A
Arab J Urol; 2020 Aug; 19(1):2-8. PubMed ID: 33763243
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.
Vetterlein MW; Wankowicz SAM; Seisen T; Lander R; Löppenberg B; Chun FK; Menon M; Sun M; Barletta JA; Choueiri TK; Bellmunt J; Trinh QD; Preston MA
Cancer; 2017 Nov; 123(22):4346-4355. PubMed ID: 28743155
[TBL] [Abstract][Full Text] [Related]
25. Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.
Lughezzani G; Sun M; Jeldres C; Alasker A; Budäus L; Shariat SF; Latour M; Widmer H; Duclos A; Jolivet-Tremblay M; Montorsi F; Perrotte P; Karakiewicz PI
Urology; 2010 Feb; 75(2):376-81. PubMed ID: 20022091
[TBL] [Abstract][Full Text] [Related]
26. National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013.
Bateni ZH; Pearce SM; Zainfeld D; Ballas L; Djaladat H; Schuckman AK; Daneshmand S
Eur Urol Oncol; 2020 Jun; 3(3):343-350. PubMed ID: 31317867
[TBL] [Abstract][Full Text] [Related]
27. Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy.
Green DA; Rink M; Hansen J; Cha EK; Robinson B; Tian Z; Chun FK; Tagawa S; Karakiewicz PI; Fisch M; Scherr DS; Shariat SF
BJU Int; 2013 Mar; 111(3):404-11. PubMed ID: 22805163
[TBL] [Abstract][Full Text] [Related]
28. Radical cystectomy versus bladder-preserving therapy for muscle-invasive urothelial carcinoma: examining confounding and misclassification biasin cancer observational comparative effectiveness research.
Bekelman JE; Handorf EA; Guzzo T; Evan Pollack C; Christodouleas J; Resnick MJ; Swisher-McClure S; Vaughn D; Ten Have T; Polsky D; Mitra N
Value Health; 2013 Jun; 16(4):610-8. PubMed ID: 23796296
[TBL] [Abstract][Full Text] [Related]
29. Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy.
Lucca I; Hofbauer SL; Leitner CV; de Martino M; Özsoy M; Susani M; Shariat SF; Klatte T
Urology; 2016 Sep; 95():132-8. PubMed ID: 27316373
[TBL] [Abstract][Full Text] [Related]
30. The Effect of Sex on Disease Stage and Survival after Radical Cystectomy in Non-Urothelial Variant-Histology Bladder Cancer.
Flammia RS; Tufano A; Chierigo F; Würnschimmel C; Hoeh B; Sorce G; Tian Z; Anceschi U; Leonardo C; Del Giudice F; Terrone C; Giordano A; Morrione A; Saad F; Shariat SF; Briganti A; Montorsi F; Chun FKH; Gallucci M; Karakiewicz PI
J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902562
[TBL] [Abstract][Full Text] [Related]
31. Molecular Subtyping of Clinically Localized Urothelial Carcinoma Reveals Lower Rates of Pathological Upstaging at Radical Cystectomy Among Luminal Tumors.
Lotan Y; Boorjian SA; Zhang J; Bivalacqua TJ; Porten SP; Wheeler T; Lerner SP; Hutchinson R; Francis F; Davicioni E; Svatek RS; Chen CL; Black PC; Gibb EA
Eur Urol; 2019 Aug; 76(2):200-206. PubMed ID: 31092337
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy.
Seisen T; Jamzadeh A; Leow JJ; Rouprêt M; Cole AP; Lipsitz SR; Kibel AS; Nguyen PL; Sun M; Menon M; Bellmunt J; Choueiri TK; Trinh QD
JAMA Oncol; 2018 Feb; 4(2):225-229. PubMed ID: 28837718
[TBL] [Abstract][Full Text] [Related]
33. Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: a SEER database analysis.
Canter D; Egleston B; Wong YN; Smaldone MC; Simhan J; Greenberg RE; Uzzo RG; Kutikov A
Urol Oncol; 2013 Aug; 31(6):866-70. PubMed ID: 21906968
[TBL] [Abstract][Full Text] [Related]
34. Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.
Abdollah F; Sun M; Schmitges J; Djahangirian O; Tian Z; Jeldres C; Perrotte P; Shariat SF; Montorsi F; Karakiewicz PI
BJU Int; 2012 Apr; 109(8):1147-54. PubMed ID: 21883849
[TBL] [Abstract][Full Text] [Related]
35. Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter study.
Laukhtina E; Boehm A; Peyronnet B; Bravi CA; Batista Da Costa J; Soria F; D'Andrea D; Rajwa P; Quhal F; Yanagisawa T; König F; Mostafaei H; Enikeev D; Ingels A; Verhoest G; D'Hondt F; Mottrie A; Joniau S; Van Poppel H; de la Taille A; Bensalah K; Bruyère F; Shariat SF; Pradere B
World J Urol; 2022 Jul; 40(7):1689-1696. PubMed ID: 35596017
[TBL] [Abstract][Full Text] [Related]
36. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
[TBL] [Abstract][Full Text] [Related]
37. Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer.
Rosiello G; Palumbo C; Knipper S; Pecoraro A; Dzyuba-Negrean C; Luzzago S; Tian Z; Gallina A; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Urol Oncol; 2020 Mar; 38(3):76.e1-76.e9. PubMed ID: 31761614
[TBL] [Abstract][Full Text] [Related]
38. Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy.
Mazzone E; Nazzani S; Knipper S; Tian Z; Preisser F; Gallina A; Soulières D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Wisnivesky J; Karakiewicz PI
Eur J Surg Oncol; 2019 Jul; 45(7):1253-1259. PubMed ID: 30755341
[TBL] [Abstract][Full Text] [Related]
39. Laparoendoscopic Single-Site Radical Cystectomy vs Conventional Laparoscopic Radical Cystectomy for Patient with Bladder Urothelial Carcinoma: Matched Case-Control Analysis.
Xu K; Lang B; Fu B; Shi T; Wang B; Zhang X
J Endourol; 2017 Dec; 31(12):1259-1268. PubMed ID: 28967303
[TBL] [Abstract][Full Text] [Related]
40. Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma.
Flammia RS; Chierigo F; Würnschimmel C; Horlemann B; Hoeh B; Sorce G; Tian Z; Leonardo C; Tilki D; Terrone C; Saad F; Shariat SF; Montorsi F; Chun FK; Gallucci M; Karakiewicz PI
Urol Oncol; 2022 Apr; 40(4):165.e9-165.e15. PubMed ID: 34686429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
